This topic contains a solution. Click here to go to the answer

Author Question: __________ is NOT sufficient evidence to categorize an individual by race. a. A physical ... (Read 32 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
__________ is NOT sufficient evidence to categorize an individual by race.
 
  a. A physical characteristic
  b. Genetic information
  c. Both of the above.
  d. None of the above.

Question 2

Exclusion of the targeted culture from a counseling theory may result in
 
  a. misdiagnosis.
  b. misunderstanding of particular meanings of concepts and behaviors.
  c. clients running the risk of being considered deficient.
  d. All of the above.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jessicaduplan

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

c

Answer to Question 2

d





 

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library